Results 31 to 40 of about 440,184 (328)

Controlled release delivery of penciclovir via a silicone (MED-4750) polymer: kinetics of drug delivery and efficacy in preventing primary feline herpesvirus infection in culture [PDF]

open access: yes, 2012
Peripheral T-cell lymphoma (PTCL) represents a relatively rare group of heterogeneous non-Hodgkin lymphomas, with generally poor prognosis. Historically, there has been a lack of consensus regarding appropriate therapeutic measures for the disease, with ...
Samantha L Semenkow   +3 more
core   +2 more sources

Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling

open access: yesLeukemia, 2019
Peripheral T-cell lymphoma, not otherwise specified (PTCL, NOS) is a diagnosis of exclusion, being the most common entity in mature T-cell neoplasms, and its molecular pathogenesis remains significantly understudied.
Yosaku Watatani   +41 more
semanticscholar   +1 more source

A case of primary peripheral T-cell type non-Hodgkin lymphoma originating in the iris: Clinico-pathological findings [PDF]

open access: yes, 2010
Background. The ocular adnexal region is the primary localization of extranodal lymphoma in 5% to 15% of all Non-Hodgkin lymphoma. Intraocular lymphoma of T-cell origin is extremely rare and such sites of infiltration have been rarely observed in ...
Jaković Ljubomir   +6 more
core   +1 more source

Reproducing the Molecular Subclassification of Peripheral T-cell Lymphoma-NOS by Immunohistochemistry.

open access: yesBlood, 2019
Peripheral T-cell lymphoma (PTCL) is a heterogeneous group of mature T-cell malignancies with approximately one-third of cases designated as PTCL-not otherwise specified (PTCL-NOS).
Catalina Amador   +29 more
semanticscholar   +1 more source

FDA Approval Summary: Brentuximab Vedotin in First‐Line Treatment of Peripheral T‐Cell Lymphoma

open access: yesThe Oncologist, 2019
This article summarizes the clinical review and basis of approval of brentuximab vedotin in combination with cyclophosphamide, doxorubicin, and prednisone as a first‐line regimen for patients with CD30‐expressing peripheral T‐cell lymphoma.
Nicholas   +16 more
semanticscholar   +1 more source

The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective, International T-Cell Project

open access: yesHaematologica, 2018
This analysis explored factors influencing survival of patients with primary refractory and relapsed peripheral T-cell lymphomas enrolled in the prospective International T-cell Project.
M. Bellei   +19 more
semanticscholar   +1 more source

Lymphoma of the Uvula: Clinical, Morphological, Histopathological, and Genetic Characterization. A Nationwide Danish Study From 1980 to 2019

open access: yesFrontiers in Surgery, 2021
Background: In the head and neck region the uvula is a rare site for extranodal lymphomas to develop. In this national study, we present six cases and provide an overview of the current literature, characterizing the clinical and histopathological ...
Lars Iversen   +10 more
doaj   +1 more source

Peculiarities of polyneuropathy in the peripheral t-cell lymphoma with cytostatics [PDF]

open access: yes, 2015
This paper presents data on the occurrence and form of polyneuropathy in the peripheral T-cell lymphoma, and its main pathogenesis elements. Here the toxic effects of cytotoxic drugs and their role in the impairment of the nervous system have been ...
Avdeeva, I. V.   +2 more
core   +2 more sources

Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified

open access: yesModern Pathology, 2019
Peripheral T-cell lymphoma not otherwise specified represents a diagnostic category comprising clinically, histologically, and molecularly heterogeneous neoplasms that are poorly understood.
M. Laginestra   +18 more
semanticscholar   +1 more source

Peripheral T cell lymphoma in Asia [PDF]

open access: yesInternational Journal of Hematology, 2014
Peripheral T-cell lymphomas (PTCLs) comprise a heterogeneous group of mature T- and NK-cell neoplasms, the incidence of which is higher in Asian countries than in Western countries. Although its etiology is mainly unknown, several risk factors (such as genetic factors, abnormal immunity, environmental factors, and infectious causes) have been proposed.
Young Hyeh Ko, Sanghui Park
openaire   +3 more sources

Home - About - Disclaimer - Privacy